ALLERGIC RHINITIS AND ADENOID HYPERTROPHY IN CHILDREN: IS ADENOIDECTOMY ALWAYS REALLY USEFUL?

L Colavita1, M Miraglia Del Giudice2, G Stroscio3

  • 11 Department of Pediatrics, Unit of Genetics and Pediatric Immunology, University of Messina, Policlinico “G. Martino”, Messina, Italy.

Insights

Adenoidectomy offers limited benefits for children with allergic rhinitis (AR) and adenoid hypertrophy (AH). Medical anti-allergic therapy is crucial for managing local inflammation and improving nasal symptoms in pediatric patients.

Area of Science:

  • Pediatric Otolaryngology
  • Allergy and Immunology
  • Pediatric Respiratory Medicine

Background:

  • Allergic rhinitis (AR) and adenoid hypertrophy (AH) frequently coexist in children.
  • Medical anti-allergic therapy has shown promise in improving respiratory symptoms and reducing adenoid volume.

Purpose of the Study:

  • To retrospectively evaluate the effectiveness of adenoidectomy on respiratory symptoms in pediatric patients diagnosed with allergic rhinitis.

Main Methods:

  • Recruited 404 pediatric patients with AR, classified into four groups based on ARIA criteria.
  • Assessed patient history, allergy markers (IgE, SPT), and presence of AH via fibroscopy.
  • Evaluated adenoidectomy efficacy on respiratory symptoms post-surgery.

Main Results:

  • A significant association was found between AR and AH, with 22% of AR patients exhibiting significant AH.
  • Adenoidectomy provided unsatisfactory benefits for 80% of AR patients, with persistent or recurrent rhinitic symptoms.
  • Common post-adenoidectomy issues included persistent nasal obstruction and recurrent respiratory tract infections.

Conclusions:

  • Adenoidectomy is often ineffective as a primary treatment for pediatric AR with AH due to persistent local inflammation.
  • Medical anti-allergic therapy is essential to manage nasal mucosal and adenoid inflammation.
  • Treating local inflammation medically is key to improving symptoms and preventing adenoid regrowth.

Related Concept Videos

Chronic Pharyngitis01:23

Chronic Pharyngitis

Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
14.9K
Drugs Used in Upper Respiratory Disorders: Overview01:16

Drugs Used in Upper Respiratory Disorders: Overview

Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
996
Upper Respiratory Drugs: Decongestants01:27

Upper Respiratory Drugs: Decongestants

Decongestants are a class of medications used primarily to alleviate nasal congestion, a common symptom resulting from allergies, colds, sinusitis, and other upper respiratory tract infections. These drugs work by activating α-adrenergic receptors, constricting small blood vessels in the nasal membranes. This action results in the opening of clogged nasal passages, thereby facilitating sinus drainage and relieving congestion.
Most decongestants are readily available over-the-counter in...
1.3K
Adrenergic Agonists: Therapeutic Uses01:30

Adrenergic Agonists: Therapeutic Uses

Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
2.2K
Adrenergic Agonists: Mixed-Action Agents01:28

Adrenergic Agonists: Mixed-Action Agents

Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
1.7K
Adrenergic Agonists: Therapeutic Classification01:18

Adrenergic Agonists: Therapeutic Classification

Adrenergic agonists can be classified based on their therapeutic uses and mechanisms of action. They serve various purposes in clinical applications.
Vasopressor or pressor agents: They increase blood pressure and function as cardiac stimulants. Examples include endogenous catecholamines (norepinephrine and dopamine) and synthetic agents (phenylephrine).
Bronchodilators: β2-agonists can relax bronchial muscles and widen airways. They are commonly used for treating obstructive pulmonary...
1.9K